Also upregulated is S1PR1 (sphingosine-1-phosphate receptor 1, also described as S1P1), increased levels of which are known to avert T cell sequestration and license immunotherapeutic responses to glioma (5). This evidence concerns the gene S1PR1 and central nervous system cancer.